The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: We will evaluate the efficacy and safety of Ivermectin in patients with mild and moderately severe COVID-19. TRIAL DESIGN: This is a phase 3, single-center, randomized, open-label, controlled trial with a 2-arm parallel-group design (1:1 ratio). PARTICIPANTS: The Severe Acute Respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini, Fatemeh Sadat, Malektojari, Alireza, Ghazizadeh, Sara, Hassaniazad, Mehdi, Davoodian, Parivash, Dadvand, Habib, Nikpoor, Amin Reza, Nikoofal-Sahlabadi, Sara, Kahoori, Sara, Sepandi, Mojtaba, Hassanipour, Soheil, Fathalipour, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780209/
https://www.ncbi.nlm.nih.gov/pubmed/33397429
http://dx.doi.org/10.1186/s13063-020-04988-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780209/
https://www.ncbi.nlm.nih.gov/pubmed/33397429
http://dx.doi.org/10.1186/s13063-020-04988-7

Ejemplares similares